Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

Recent research highlights a concerning trend: pregnant people with multiple sclerosis are more prone to mental illnesses ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

The following is a summary of “Real-world satisfaction and experience with injection and autoinjector device for ofatumumab ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

From 1996-2024, 82 cases of anaphylaxis associated with glatiramer acetate were reported to the FDA Adverse Event Reporting ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...